Cytarabine ocfosfate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCytarabine ocfosfate
Drug Alias NameAra CMP stearyl esterPhosteabine sodiumFosteabineEstarabineCytarabine phosphate stearate +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsLeukemia
Global Approved IndicationsLeukemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/12/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co LtdYamasa Corp
China Registration ClassN/A

Develop Information

Active CompaniesNippon Kayaku Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeL01BC01
Related LinksKEGG